Skip to main content
. 2017 Jul 27;12(7):e0179726. doi: 10.1371/journal.pone.0179726

Table 5. Association of RAS/RAF oncogene family member mutations with estimates of immune cell types across TCGA.

Variant Signature Bladder Colon Testicular Thyroid
BRAF mutant MFm2 0.4 (2.7)
BRAF mutant Mono 0.45 (3.9)
BRAF mutant NK 0.58 (1.4)
BRAF mutant NKCD8 -0.38 (3.9)
BRAF mutant Tcell 0.48 (6)
BRAF mutant Treg 0.66 (14.9)
BRAF mutant TregCD8 0.43 (5.9)
BRAF V600E MFm2 0.45 (3.1)
BRAF V600E Mono 0.54 (5.2)
BRAF V600E NKCD8 -0.37 (3.1)
BRAF V600E Tcell 0.59 (10.1)
BRAF V600E Treg 0.75 (19.8)
BRAF V600E TregCD8 0.49 (7.9)
KRAS G12V MFm2 -2.81 (2.8)
NRAS mutant Bcell -0.8 (3.7)
NRAS mutant Tcell -0.82 (4.7)
NRAS mutant Treg -0.74 (3.6)
NRAS Q61R Bcell -0.81 (2.2)
NRAS Q61R NK 1.64 (2.4)
NRAS Q61R Tcell -0.82 (2.8)
NRAS Q61R Treg -0.7 (2.2)

Values are reported as Effect Size with associated P values in parenthesis (-log10 P). The units of effect size are change in signature score (units of standard deviation) for mutant versus wild type.